Finance

Lists
Why is NBTX up 3,41%?
Dive Deeper
NBTX:NASDAQ
Nanobiotix SA - ADR
23,68 US$
+3,41%
(+0,78) 1D
9 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NBTX...
Open
23,51 US$
High
24,50 US$
Low
23,33 US$
Mkt. cap
1,21 მლრდ.
Avg. vol.
150,34 ათ.
Volume
93,50 ათ.
52-wk high
57,00 US$
52-wk low
14,78 US$
EPS
-1,22 US$
Beta
0,74
Shares outstanding
50,83 მლნ.
No. of employees
98
Open
23,51 US$
High
24,50 US$
Low
23,33 US$
Mkt. cap
1,21 მლრდ.
Avg. vol.
150,34 ათ.
Volume
93,50 ათ.
52-wk high
57,00 US$
52-wk low
14,78 US$
EPS
-1,22 US$
Beta
0,74
Shares outstanding
50,83 მლნ.
No. of employees
98
News stories
From web sources and news partners
Ideal Investisseur
Ideal Investisseur
·
2 დღის წინ
35.5% decline in one month for Nanobiotix share, which gains 2%
Profile
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
About Nanobiotix SA - ADR
CEOლორან ლევი
Employees98
Founded2003
Headquarters-
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to NBTX in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NBTX in the last 3 months.
Highest
Current 23,68 US$
64,00 US$ (+170,27%)
Average
47,00 US$ (+98,48%)
Lowest
30,00 US$ (+26,69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Jeng
Guggenheim
Buy
Maintained
64,00 US$
+170,3%
09/25/2026
David Dai
UBS
Hold
Maintained
30,00 US$
+26,7%
09/25/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
09/25/2026
Michael Schmidt
Guggenheim
Buy
Reiterated
36,00 US$
+52%
05/05/2026
Jonathan Chang
Leerink Partners
Buy
Maintained
37,00 US$
+56,2%
04/01/2026
Unknown Analyst
Guggenheim
Buy
Maintained
26,00 US$
+9,8%
02/05/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
2,98 მლნ.
2,98 მლნ.
2,78 მლნ.
2,78 მლნ.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,29 მლნ.
4,29 მლნ.
6,36 მლნ.
6,36 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,53 მლნ.
4,53 მლნ.
5,38 მლნ.
5,38 მლნ.
Operating expense
8,83 მლნ.
8,83 მლნ.
11,74 მლნ.
11,74 მლნ.
Total operating expenses
8,83 მლნ.
8,83 მლნ.
11,74 მლნ.
11,74 მლნ.
Operating income
-5,85 მლნ.
-5,85 მლნ.
-8,96 მლნ.
-8,96 მლნ.
Other non operating income
-8,50 ათ.
-8,50 ათ.
-1,00 ათ.
-1,00 ათ.
EBT including unusual items
-9,29 მლნ.
-9,29 მლნ.
-17,14 მლნ.
-17,14 მლნ.
EBT excluding unusual items
-8,57 მლნ.
-8,57 მლნ.
-16,56 მლნ.
-16,56 მლნ.
Income tax expense
-1,50 ათ.
-1,50 ათ.
8,00 ათ.
8,00 ათ.
Effective tax rate
0,02%
0,02%
-0,05%
-0,05%
Other operating expenses
-
-
-
-
Net income
-9,29 მლნ.
-9,29 მლნ.
-17,14 მლნ.
-17,14 მლნ.
Net profit margin
-311,97%
-311,97%
-617,69%
-617,69%
Earnings per share
-
-
-
-
Interest and investment income
193,50 ათ.
193,50 ათ.
338,50 ათ.
338,50 ათ.
Interest expense
-3,08 მლნ.
-3,08 მლნ.
-7,28 მლნ.
-7,28 მლნ.
Net interest expenses
-2,88 მლნ.
-2,88 მლნ.
-6,94 მლნ.
-6,94 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,79 მლნ.
-5,79 მლნ.
-8,84 მლნ.
-8,84 მლნ.
Gain or loss from assets sale
76,50 ათ.
76,50 ათ.
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები